Medication info
Procyta Tablet 50 mg (Sitagliptin Hydrochloride Monohydrate)

Procyta Tablet 50 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
Ajou Pharmaceuticals Co., Ltd.
Appearance
Light apricot-colored, round, biconvex film-coated tablet
Packaging
28 tablets/box [14 tablets/PITP*2]
Approval status
Active

MFDS item code 202101371 · Approved 2021.02.17 · Insurance code 654006100

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medication is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (refer to Precautions, 5. General Precautions). Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medication and periodically thereafter. No dosage adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Ajou Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used along with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with metformin if the patient has no previous experience with diabetes medication and is having difficulty controlling blood sugar alone. Additionally, it can be used in combination with sulfonylureas, metformin, thiazolidinediones, or insulin when blood sugar control is insufficient with those agents alone. In combination therapy, if blood sugar control is still inadequate despite using metformin or other agents together, this medication can be added. This medication is effective in improving blood sugar control.

How to take

Adult dose

This medication is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (refer to Precautions, 5. General Precautions). Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medication and periodically thereafter. No dosage adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered regardless of the timing of dialysis.

Precautions

This medication may rarely cause serious allergic reactions; therefore, if symptoms such as skin rash, difficulty breathing, or swelling of the face or lips occur after taking the medication, stop taking it immediately and consult a doctor. Also, pancreatitis, which is inflammation of the pancreas, may occur during treatment with this medication, so if symptoms such as abdominal pain, vomiting, or loss of appetite appear, notify healthcare personnel immediately. This medication should not be used by patients with type 1 diabetes or diabetic ketoacidosis, and patients who are allergic to this medication or its components should not take it. Patients with impaired kidney function may experience slowed excretion of this medication, so dosage adjustments should be made as directed by a physician, and regular kidney function tests are important. While taking this medication, side effects such as upper respiratory infections, nasopharyngitis, headache, diarrhea, etc., may occur; if symptoms are severe or persist for a long time, consult a doctor. Particularly, when taken with insulin or sulfonylurea, hypoglycemic symptoms may occur, so blood sugar levels should be monitored regularly, and dosage adjustments may be necessary if required. Rare side effects such as severe joint pain or blistering skin diseases have also been reported, so if there is severe pain in the joints or blistering or rashes on the skin, inform healthcare personnel immediately. Pregnant or breastfeeding women should avoid using this medication as its safety has not been established, and it is not recommended for children or adolescents under 18 years of age. In case of overdose, general emergency care should be received, and if necessary, blood dialysis may be performed to remove the medication; thus, care should be taken not to exceed the prescribed dose. Finally, this medication tends to have fewer drug interactions, but if taken with cyclosporine or digoxin, changes in blood concentration may occur, so it is essential to inform the doctor about other medications being taken and to undergo regular monitoring.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 28 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best to keep the storage temperature between 1 and 30 degrees Celsius at room temperature, which will help maintain the medication's effectiveness for a prolonged period.

Appearance and packaging

Appearance

Light apricot-colored, round, biconvex film-coated tablet

Package unit

28 tablets/box [14 tablets/PITP*2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.